
Renascience
4889.TRenascience Inc. Price (4889.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
12,711,700
(0)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
Renascience Inc.Currency: JPY
YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
72,000,000.00
+0% |
209,802,000.00
+191% |
139,333,000.00
-34% |
100,545,000.00
-28% |
194,165,000.00
+93% |
||||||||||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 20,000,000.00 | 29,977,000.00 | 58,363,000.00 | 250,000.00 | 28,521,000.00 | ||||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
52,000,000.00
+0% |
179,825,000.00
+246% |
80,970,000.00
-55% |
100,295,000.00
+24% |
165,644,000.00
+65% |
||||||||||||||
Gross Profit Ratio | (0.72%) | (0.86%) | (0.58%) | (1.00%) | (0.85%) | ||||||||||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 26,004,000.00 | 81,434,000.00 | 82,000,000.00 | 235,000,000.00 | 236,000,000.00 | ||||||||||||||
General and Administrative | 0.00 | 0.00 | 53,000,000.00 | 50,000,000.00 | 48,000,000.00 | ||||||||||||||
Selling, General & Admin... | 235,000,000.00 | 265,000,000.00 | 193,000,000.00 | 185,000,000.00 | 167,000,000.00 | ||||||||||||||
Selling & Marketing Exp... | 0.00 | 0.00 | 140,000,000.00 | 135,000,000.00 | 119,000,000.00 | ||||||||||||||
Depreciation and Amortiz... | 183,000,000.00 | 2,868,000.00 | 3,074,000.00 | 1,378,000.00 | 1,837,000.00 | ||||||||||||||
Other Expenses | -5,734,000.00 | 1,757,000.00 | 42,000.00 | 5,000.00 | 14,979,000.00 | ||||||||||||||
Total Operating Expenses | 236,000,000.00 | 265,950,000.00 | 291,810,000.00 | 434,166,000.00 | 417,979,000.00 | ||||||||||||||
Cost and Exponses | 256,000,000.00 | 295,927,000.00 | 350,173,000.00 | 434,416,000.00 | 446,500,000.00 | ||||||||||||||
Operating Income | |||||||||||||||||||
Operating Income |
-183,000,000.00
+0% |
-86,125,000.00
-53% |
-210,839,000.00
+145% |
-333,870,000.00
+58% |
-252,335,000.00
-24% |
||||||||||||||
Operating Income Ratio | (-2.54%) | (-0.41%) | (-1.51%) | (-3.32%) | (-1.30%) | ||||||||||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 17,000.00 | 43,000.00 | 20,000.00 | 26,000.00 | 24,000.00 | ||||||||||||||
Interest Expenses | 678,000.00 | 7,504,000.00 | 5,366,000.00 | 0.00 | 0.00 | ||||||||||||||
Total Other Income/Exp... | -670,000.00 | -13,632,000.00 | -42,249,000.00 | 31,000.00 | -4,042,000.00 | ||||||||||||||
EBITDA | |||||||||||||||||||
EBITDA | -180,083,000.00 | -80,357,000.00 | -244,648,000.00 | -332,493,000.00 | -250,499,000.00 | ||||||||||||||
EBITDA ratio | (-0.01%) | (-0.38%) | (-1.67%) | (-3.31%) | (-1.29%) | ||||||||||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | -184,000,000.00 | -99,757,000.00 | -253,088,000.00 | -333,839,000.00 | -256,377,000.00 | ||||||||||||||
Income Before Tax Ratio | (-2.56%) | (-0.48%) | (-1.82%) | (-3.32%) | (-1.32%) | ||||||||||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | -1,000,000.00 | 296,000.00 | 1,204,000.00 | 1,958,000.00 | 1,957,000.00 | ||||||||||||||
Net Income | |||||||||||||||||||
Net Income | -184,000,000.00
+0% |
-100,054,000.00
-46% |
-254,292,000.00
+154% |
-335,797,000.00
+32% |
-258,334,999.00
-23% |
||||||||||||||
Net Income Ratio | (-2.56%) | (-0.48%) | (-1.83%) | (-3.34%) | (-1.33%) | ||||||||||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | -15.00 | -10.19 | -22.33 | -26.42 | -20.32 | ||||||||||||||
Diluted EPS | -15.00 | -10.19 | -22.33 | -26.42 | -20.32 | ||||||||||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 12,269,000.00 | 9,819,082.00 | 11,389,120.00 | 12,711,700.00 | 12,711,700.00 | ||||||||||||||
Diluted Share Outstanding | 12,269,000.00 | 9,819,082.00 | 11,389,120.00 | 12,711,700.00 | 12,711,700.00 |